Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-09-19A Phase 2, Open-Label, Dose-Escalation Study in Subjects With Pulmonary Arterial Hypertension, (PAH, WHO Group 1) and Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis, (PH-IPF WHO Group 3) Using Inhaled GeNOsyl.
-
CLINICAL_TRIALS study record update · 2016-09-01Investigating the Role of the Coagulation Cascade in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-07-01Exhaled Breath Condensate Biomarkers and Cough in People With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-06-13Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-05-20A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N-Acetylcysteine in Patients With Idiopathic Pulmonary Fibrosis With Background Treatment of Pirfenidone
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-03-09An Open-Label, Phase 2 Study of the Safety of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-02-15Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2016-01-05A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
-
CLINICAL_TRIALS study record update · 2015-12-29A Phase I Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-12-03Phase II Trial of Zileuton Compared to Azathioprine/Prednisone for the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-12-02The Role of Microaspiration in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-11-30Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-10-27Reliability of the 4 Metre Gait Speed in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-09-03Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2015-07-13A Treatment Protocol to Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone
-
CLINICAL_TRIALS study record update · 2015-07-09A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-6624 in Adult Subjects With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-06-30Default Options in Advance Directives for Veterans With Serious Illnesses: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2015-04-21Determinants of Outcome in Diffuse Parenchymal Lung Disease
-
CLINICAL_TRIALS study record update · 2015-04-13Phase I, Open-Label, Multi-Center, Single-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic of GC1008 in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-04-10Conducting Airways in Lung Fibrosis
-
CLINICAL_TRIALS study record update · 2015-04-09The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2015-03-12A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study of the Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (ASCEND Trial)
-
CLINICAL_TRIALS study record update · 2015-01-27Employment of 68Ga-DOTA-NOC in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-01-16Rehabilitation of IPF Patients: Effects of Exercise and Oxidant Stress
-
CLINICAL_TRIALS study record update · 2015-01-06A Double-blind, Randomised, Placebo-controlled (Within a Dose Group) Study to Evaluate Safety and Pharmacokinetics of Multiple Rising Doses of BIBF 1120 at 50 mg Bid (14 Days), 100 mg Bid (14 Days), and 150 mg Bid (28 Days) p.o., on Top of Standard Medical Care With Stratification According to Pirfenidone Use, in Japanese Patients With Idiopathic Pulmonary Fibrosis.